← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Drug Delivery Company, Llc, The
Salisbury, MD
$13,232,124
Total funding
3
Grants
Funding over time
peak $5.6M · FY2019–25$10M$7.5M$5M$2.5M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,232,124 · 3
By mechanism
UG3$8,717,301 · 2
UH3$4,514,823 · 1
Investigators at Drug Delivery Company, Llc, The
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
A Long-Acting Bioabsorbable Naltrexone Subcutaneous Implant for Opioid Use Disorder$3,083,969
UG3 · FY2019 · DA
Development of a bioabsorbable, subcutaneous, extended-release buprenorphine implant for opioid use disorder$2,932,500
UG3 · FY2025 · DA
A Long-Acting Bioabsorbable Naltrexone Subcutaneous Implant for Opioid Use Disorder$2,708,703
UH3 · FY2025 · DA
A Long-Acting Bioabsorbable Naltrexone Subcutaneous Implant for Opioid Use Disorder$2,700,832
UG3 · FY2020 · DA
A Long-Acting Bioabsorbable Naltrexone Subcutaneous Implant for Opioid Use Disorder$1,806,120
UH3 · FY2024 · DA